[ad_1]
Germany‘s Ambassador to Beijing Patricia Flor announced that German citizens in mainland China will be able to benefit from the BioNTech vaccine in the coming weeks.
During German Chancellor Olaf Scholz’s visit to Beijing last month, an agreement was reached for the limited application of the vaccine, which has not yet been approved for use on the mainland, to German citizens. Scholz expressed his wish that the limited use approval would be the first step towards widespread use of the vaccine.
German Government Spokesperson Steffen Hebestreit said in a statement yesterday that they were waiting for the plane carrying the vaccines to reach Beijing.
FIRST IMPORTED VACCINE IN Mainland CHINA
The vaccine developed by the BioNTech company, founded by Turkish scientist Uğur Şahin, will be the first imported vaccine used in mainland China.
Until now, the use of Covid-19 vaccines other than those produced by Chinese companies Sinopharm, Sinovac and CanSino Biotech has not been approved in mainland China.
While the vaccine, whose production and distribution rights in China are held by Fosun Pharma, is not used in the mainland, it is administered in China’s Hong Kong and Macau Special Administrative Regions and Taiwan, which is in a sovereignty dispute with China.
[ad_2]
Source link
